Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-30

Clinical Trial Update: Effectiveness of Butylphthalide on Dynamic Cerebral Autoregulation in Patients With Acute Ischemic Stroke. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated the effectiveness of butylphthalide on dynamic cerebral autoregulation in patients with acute ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Butylphthalide (butylphthalide)

Snippet

Sponsor: Yi Yang | Conditions: Acute Ischemic Stroke | Phase 4 | Status: COMPLETED